Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume → Don’t expose yourself to stocks during the week (From DTI) (Ad) Free LEXX Stock Alerts $2.24 -0.01 (-0.44%) (As of 11:44 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexaria Bioscience Short Interest DataCurrent Short Volume490,400 sharesPrevious Short Volume754,500 sharesChange Vs. Previous Month-35.00%Dollar Volume Sold Short$1.78 millionShort Interest Ratio / Days to Cover1.1Last Record DateMarch 31, 2024Outstanding Shares12,890,000 sharesFloat Size11,530,000 sharesShort Percent of Float4.25%Today's Trading Volume22,554 sharesAverage Trading Volume430,738 sharesToday's Volume Vs. Average5% Short Selling Lexaria Bioscience ? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLEXX Short Interest Over TimeLEXX Days to Cover Over TimeLEXX Percentage of Float Shorted Over Time Ad Tips4TradersUncover this 2024 Hidden GemExclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today. Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63 3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90 2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45 2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36 1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49 1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51 Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25 12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27 11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50 11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34 10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38 10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92 9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00 9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87 8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05 8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11 7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83 7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83 6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73 6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69 5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74 5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72 4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09 4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18 3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72 3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71 2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03 2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97 1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21 1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77 12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46 12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79 11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96 11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41 10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21 10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11 9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45 9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93 8/31/2022334,400 shares $989,824.00 -0.1%6.2%6.2 $2.96 8/15/2022334,600 shares $1.07 million -0.1%6.2%5.6 $3.20The system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! LEXX Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 490,400 shares of LEXX short. 4.25% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest. What is a good short interest ratio for Lexaria Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEXX shares currently have a short interest ratio of 1.0. Learn More on Lexaria Bioscience's short interest ratio. What is a good short interest percentage for Lexaria Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.25% of Lexaria Bioscience's floating shares are currently sold short. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a drop in short interest in March. As of March 31st, there was short interest totaling 490,400 shares, a drop of 35.0% from the previous total of 754,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lexaria Bioscience's float size? Lexaria Bioscience currently has issued a total of 12,890,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 11,530,000 shares. How does Lexaria Bioscience's short interest compare to its competitors? 4.25% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lexaria Bioscience: CASI Pharmaceuticals, Inc. (1.31%), Spruce Biosciences, Inc. (1.46%), Aprea Therapeutics, Inc. (2.35%), Theratechnologies Inc. (0.06%), Viracta Therapeutics, Inc. (2.37%), Aptorum Group Limited (3.91%), Enlivex Therapeutics Ltd. (1.27%), JanOne Inc. (2.92%), Forte Biosciences, Inc. (0.09%), Sol-Gel Technologies Ltd. (0.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CASI Pharmaceuticals Short Squeeze Spruce Biosciences Short Squeeze Aprea Therapeutics Short Squeeze Theratechnologies Short Squeeze Viracta Therapeutics Short Squeeze Aptorum Group Short Squeeze Enlivex Therapeutics Short Squeeze JanOne Short Squeeze Forte Biosciences Short Squeeze Sol-Gel Technologies Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchUrgent alert: open this for a huge profit potentialTimothy Sykes